When board choices are tied to humanity’s future
Few listed companies claim that the future of humanity hinges on seemingly dry choices about board composition. Anthropic is an exception. The company has warned that AI could one day help cure cancer but could also pose catastrophic risks, and its IPO filing shows it has thought carefully about who will be in charge as the technology advances rapidly.
Anthropic is organized as a public benefit corporation under Delaware law, meaning its board must balance investor interests with promoting a wider good. The company plans to list on Nasdaq under the ticker ANT. According to Reuters, the structure shows how Anthropic has insulated itself from investor pressure to pursue what it believes is best for humanity.
Three tiers of power
The IPO filing describes a multi-layered power system in which each share class plays a distinct role:
- Class F stock, held by Founder LLC on behalf of the seven co-founders, gives them 50.1% of voting power on certain matters, including electing the remaining directors and shareholder proposals.
- Class T stock, held by the Long-Term Benefit Trust, lets the trust elect a majority of the board; the trust is currently chaired by global health leader Neil “Buddy” Shah.















